Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of May 21, 2026, ELAN trades at $20.80 with a market cap of $9.95B and a P/E ratio of -41.81. ELAN moved +5.25% today. Year to date, ELAN is -9.54%; over the trailing twelve months it is +59.40%. Its 52-week range spans $8.02 to $27.72. Analyst consensus is strong buy with an average price target of $29.18. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Elanco jumps after Q1 beat and raised 2026 outlook on innovation momentum: Elanco shares are rising after the company reported Q1 2026 results and raised full-year 2026 guidance. The company posted revenue of $1.371 billion (+15% YoY) and adjusted EPS of $0.40, while lifting 2026 revenue to $5.010–$5.085 billion and adjusted EPS to $1.03–$1.09.
| Metric | Value |
|---|---|
| Price | $20.80 |
| Market Cap | $9.95B |
| P/E Ratio | -41.81 |
| EPS | $-0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.72 |
| 52-Week Low | $8.02 |
| Volume | 152 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.89B |
| Net Income | $-242.00M |
| Gross Margin | 55.06% |
12 analysts cover ELAN: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.18.